Ann E. Anderson, MD, FCAP

Director of Pathology

Dr. Ann Anderson has served as the Director of Pathology at Integrated Medical Professionals since 2008, following 20 years at the Northwell Health System. With a strong foundation in Molecular Biology and Tumor Cytogenetics from Memorial Sloan Kettering Cancer Center (MSKCC), she pioneered the implementation of the first Physician Office Lab Shotgun Metagenomics platform for persistent urinary tract infections.

In recent years, her team has focused on advancing a comprehensive Prostate Cancer Germline Initiative (NIH 508511) , which encompasses in-house sequencing, diagnostic services, and educational programs for both physicians and patients. This initiative underscores
the critical significance of NCCN-recommended germline studies for high-risk prostate cancer patients. The next phase of this work involves transitioning to in-house somatic testing, which is currently in progress.

Dr. Anderson earned her M.D. from New York Medical College and completed her studies in Molecular Biology and Tumor Cytogenetics at MSKCC with Dr. Raju Chaganti.

Education:

Queens College

City University of New York

BA Degree, 1978

New York, Medical College

MD Degree, 1982

Post-Graduate Education:

Resident, Anatomic Pathology

North Shore University Hospital

Manhasset, New York

1985-1987

Fellow, Molecular Biology and Tumor Cytogenics

Memorial-Sloan Kettering Cancer Center

New York, New York

1987-1989

Licensure:

New York State, October 1986

Specialty Board Certification:

Diplomate, American Board of Pathology

Anatomic Pathology – June 2, 1994

Current Hospital Appointment:

South Nassau Communities Hospital

Oceanside, NY

Chairman, Department of Pathology and Clinical Laboratories

August 2007-Present

Current Academic Appointment:

Albert Einstein College of Medicine of Yeshiva University

Bronx, NY

Assistant Professor of Pathology

April 1993-Present

Awards & Honors:

Cor et Manus, New York Medical College

June 2, 1982

Best Doctors in America

Castle and Connolly

2001-2002

2003-2004

2007-2008

Professional Society Membership:

Fellow, College of American Pathologists

American Medical Association

United States and Canadian Academy of Pathology, Inc.

Interational Society of Gynecological Pathologists

United States and Canadian Academy of Pathology

Other Professional Activities:

Member, Surgical Audit Committee – LIJMC

Member, Faculty Council – LIJMC

Member, Executive Committee – Staff Society LIJMC

Member, ACOG Cervical Task Force, New York State, 2006-Present

Recent Publications:

Anderson AE, chen D-z, Sun S, Auborn K. Indole-3-Carbinol Prevents PTEN Loss in Cervical In Vivo.

Molecular Med. 11:1-12, 2005

Hassoun A, Jacquett G, Huang A, Anderson AE, Smith MA. Female Genital Tuberculosis: Uncommom Presentation of Tuberculosis in the United States.

Amer J Med 118:11, November, 2005.

Dickerman RD, Anderson AW, Morgan J, Cohen AJ. Diffuse Malignant Transformation of Pleomorphic Xanthoastrocytoma 21 years later: a Matter of Time?

Acta Neurochir 148(1):95-7, January 2006.

Anderson AW, et al. Endocervical Stromal Sarcoma.

JOB & Gyn, March 26(8):832-835, November 2006.

Ost MC, Patel KP, Rastinhad AR, Chu PY, Anderson AE, Smith A, Lee BR. Pneumoperitoneum with CO2 Inhibits Local Macrophage TNF-A secretion: An Etiology for Transitional Cell Carcinoma Port site Metastasis and Prophylactic Irrigation Strategies to Decrease Laproscopic Oncological Risks (submitted).

Vanderbrink BA, Ost MC, Levine MA, Anderson AE, Baldani GH, Smith AD, Lee BR. Laproscopic versus Open Radical Nephrectomy for the Treatment of Xanthogranulomatous Pyelonephritis: Contemporary Outcome Analysis (submitted).

IMP's Management Team:

Deepak A. Kapoor, MD

Chairman and CEO

W. Price Dunaway

Chief Operating Officer

Kathleen L. Latino, MD, FACS, CHC

Chief Medical Officer

Marc A. Schumer, MD, FACS

Associate Medical Director

Shawn H. Zimberg, MD

Director of Radiation Oncology Services

Ann E. Anderson, MD, FCAP